EUVIMEDEUVIMED entdecken
Crossref

26-A-20870-ACC LIPOPROTEIN(A) AND INCIDENT TYPE 2 DIABETES & MACE: RETHINKING RISK IN INSULIN RESISTANCE STATES

Jason Sangha, Sudipta Chattopadhyay

JACC · 2026-04 · 87 (13) · A336

DOI: 10.1016/j.jacc.2026.02.830 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC, 2026-04. Verfasst von Jason Sangha und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Sangha, J., & Chattopadhyay, S. (2026). 26-A-20870-ACC LIPOPROTEIN(A) AND INCIDENT TYPE 2 DIABETES & MACE: RETHINKING RISK IN INSULIN RESISTANCE STATES. JACC, 87(13), A336. https://doi.org/10.1016/j.jacc.2026.02.830

Vancouver

Sangha J, Chattopadhyay S. 26-A-20870-ACC LIPOPROTEIN(A) AND INCIDENT TYPE 2 DIABETES & MACE: RETHINKING RISK IN INSULIN RESISTANCE STATES. JACC. 2026;87(13):A336. doi:10.1016/j.jacc.2026.02.830

BibTeX
@article{Sangha2026,
  author = {Sangha, Jason and Chattopadhyay, Sudipta},
  title = {26-A-20870-ACC LIPOPROTEIN(A) AND INCIDENT TYPE 2 DIABETES & MACE: RETHINKING RISK IN INSULIN RESISTANCE STATES},
  journal = {JACC},
  year = {2026},
  volume = {87},
  number = {13},
  pages = {A336},
  doi = {10.1016/j.jacc.2026.02.830}
}
Kostenlos starten →